Cargando…

External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study

OBJECTIVES: To externally validate a recently developed cardiovascular disease (CVD) risk model for Omanis with type 2 diabetes mellitus (T2DM). DESIGN: Retrospective cohort study. SETTING: Nine primary care centres in Muscat Governorate, Oman. PARTICIPANTS: A total of 809 male and female adult Oman...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Oraimi, Fatema, Al Rawahi, Amani, Al Harrasi, Amira, Albusafi, Sarah, Al-Manji, Laila Mohammed, Alrawahi, Abdul Hakeem, Al Salmani, Asma Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660833/
https://www.ncbi.nlm.nih.gov/pubmed/37968004
http://dx.doi.org/10.1136/bmjopen-2022-071369
_version_ 1785148433766547456
author Al Oraimi, Fatema
Al Rawahi, Amani
Al Harrasi, Amira
Albusafi, Sarah
Al-Manji, Laila Mohammed
Alrawahi, Abdul Hakeem
Al Salmani, Asma Ali
author_facet Al Oraimi, Fatema
Al Rawahi, Amani
Al Harrasi, Amira
Albusafi, Sarah
Al-Manji, Laila Mohammed
Alrawahi, Abdul Hakeem
Al Salmani, Asma Ali
author_sort Al Oraimi, Fatema
collection PubMed
description OBJECTIVES: To externally validate a recently developed cardiovascular disease (CVD) risk model for Omanis with type 2 diabetes mellitus (T2DM). DESIGN: Retrospective cohort study. SETTING: Nine primary care centres in Muscat Governorate, Oman. PARTICIPANTS: A total of 809 male and female adult Omani patients with T2DM free of CVD at baseline were selected using a systematic random sampling strategy. OUTCOME MEASURES: Data regarding CVD risk factors and outcomes were collected from the patients’ electronic medical records between 29 August 2020 and 2 May 2021. The ability of the model to discriminate CVD risk was assessed by calculating the area under the curve (AUC) of the receiver-operating characteristic curve. Calibration of the model was evaluated using a Hosmer-Lemeshow χ(2) test and the Brier score. RESULTS: The incidence of CVD events over the 5-year follow-up period was 4.6%, with myocardial infarction being most frequent (48.6%), followed by peripheral arterial disease (27%) and non-fatal stroke (21.6%). A cut-off risk value of 11.8% demonstrated good sensitivity (67.6%) and specificity (66.5%). The area under the curve (AUC) was 0.7 (95% CI 0.60 to 0.78) and the Brier score was 0.01. However, the overall mean predicted risk was greater than the overall observed risk (11.8% vs 4.6%) and the calibration graph showed a relatively significant difference between predicted and observed risk levels in different subgroups. CONCLUSIONS: Although the model slightly overestimated the CVD risk, it demonstrated good discrimination. Recalibration of the model is required, after which it has the potential to be applied to patients presenting to diabetic care centres elsewhere in Oman.
format Online
Article
Text
id pubmed-10660833
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-106608332023-11-15 External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study Al Oraimi, Fatema Al Rawahi, Amani Al Harrasi, Amira Albusafi, Sarah Al-Manji, Laila Mohammed Alrawahi, Abdul Hakeem Al Salmani, Asma Ali BMJ Open Diabetes and Endocrinology OBJECTIVES: To externally validate a recently developed cardiovascular disease (CVD) risk model for Omanis with type 2 diabetes mellitus (T2DM). DESIGN: Retrospective cohort study. SETTING: Nine primary care centres in Muscat Governorate, Oman. PARTICIPANTS: A total of 809 male and female adult Omani patients with T2DM free of CVD at baseline were selected using a systematic random sampling strategy. OUTCOME MEASURES: Data regarding CVD risk factors and outcomes were collected from the patients’ electronic medical records between 29 August 2020 and 2 May 2021. The ability of the model to discriminate CVD risk was assessed by calculating the area under the curve (AUC) of the receiver-operating characteristic curve. Calibration of the model was evaluated using a Hosmer-Lemeshow χ(2) test and the Brier score. RESULTS: The incidence of CVD events over the 5-year follow-up period was 4.6%, with myocardial infarction being most frequent (48.6%), followed by peripheral arterial disease (27%) and non-fatal stroke (21.6%). A cut-off risk value of 11.8% demonstrated good sensitivity (67.6%) and specificity (66.5%). The area under the curve (AUC) was 0.7 (95% CI 0.60 to 0.78) and the Brier score was 0.01. However, the overall mean predicted risk was greater than the overall observed risk (11.8% vs 4.6%) and the calibration graph showed a relatively significant difference between predicted and observed risk levels in different subgroups. CONCLUSIONS: Although the model slightly overestimated the CVD risk, it demonstrated good discrimination. Recalibration of the model is required, after which it has the potential to be applied to patients presenting to diabetic care centres elsewhere in Oman. BMJ Publishing Group 2023-11-15 /pmc/articles/PMC10660833/ /pubmed/37968004 http://dx.doi.org/10.1136/bmjopen-2022-071369 Text en © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Diabetes and Endocrinology
Al Oraimi, Fatema
Al Rawahi, Amani
Al Harrasi, Amira
Albusafi, Sarah
Al-Manji, Laila Mohammed
Alrawahi, Abdul Hakeem
Al Salmani, Asma Ali
External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
title External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
title_full External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
title_fullStr External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
title_full_unstemmed External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
title_short External validation of a cardiovascular risk model for Omani patients with type 2 diabetes mellitus: a retrospective cohort study
title_sort external validation of a cardiovascular risk model for omani patients with type 2 diabetes mellitus: a retrospective cohort study
topic Diabetes and Endocrinology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660833/
https://www.ncbi.nlm.nih.gov/pubmed/37968004
http://dx.doi.org/10.1136/bmjopen-2022-071369
work_keys_str_mv AT aloraimifatema externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy
AT alrawahiamani externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy
AT alharrasiamira externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy
AT albusafisarah externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy
AT almanjilailamohammed externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy
AT alrawahiabdulhakeem externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy
AT alsalmaniasmaali externalvalidationofacardiovascularriskmodelforomanipatientswithtype2diabetesmellitusaretrospectivecohortstudy